Operator
Good afternoon, and welcome to Castle Biosciences’ Third Quarter 2025 Conference Call. As a reminder, today’s call is being recorded.
[Operator Instructions] I would like to turn the call over to Camilla Zuckero, Vice President, Investor Relations and Corporate Affairs. Please go ahead.
Camilla Zuckero
Vice President of Investor Relations & Corporate Affairs
Thank you, operator. Good afternoon, everyone. Welcome to Castle Biosciences’ Third Quarter 2025 Results Conference Call. Joining me today are Castle’s Founder, President and Chief Executive Officer, Derek Maetzold; Chief Financial Officer, Frank Stokes; and Senior Vice President, Medical, Dr. Matthew Goldberg, Board-certified dermatologist and dermatopathologist.
Information recorded on this call speaks only as of today, November 3, 2025. Therefore, if you are listening to the replay or reading the transcript of this call, any time-sensitive information may no longer be accurate. A recording of today’s call will be available on the Investor Relations page of the company’s website for approximately 3 weeks following the conclusion of the call.
Before we begin, I would like to remind you that some of the statements made today will contain forward-looking statements, including statements about expected addressable market, statements containing projections regarding future events or our future financial or operational results and performance, including our anticipated 2025 total revenue and the impact
Read the full article here
